You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

QR-010

Showing 26 - 50 of 148
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Colorectal Cancer, Metastatic Colorectal Cancer Trial in Worldwide (MRTX849, Cetuximab, mFOLFOX6 Regimen)

Recruiting
  • Advanced Colorectal Cancer
  • Metastatic Colorectal Cancer
  • Birmingham, Alabama
  • +208 more
Aug 3, 2022

Relapse/Refractory Multiple Myeloma Trial in China (ATG-010)

Completed
  • Relapse/Refractory Multiple Myeloma
  • Beijing, Beijing, China
  • +16 more
Jul 27, 2022

Dyskinesias, Parkinson Disease Trial in Miami, Detroit (Part 1, JM-010 component Group A, Part 1, JM-010 component Group B, Part

Recruiting
  • Dyskinesias
  • Parkinson Disease
  • Part 1, JM-010 component Group A
  • +7 more
  • Miami, Florida
  • +1 more
Mar 21, 2022

Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis Trial in Worldwide (sepofarsen, Sham)

Active, not recruiting
  • Leber Congenital Amaurosis 10
  • +9 more
  • Iowa City, Iowa
  • +13 more
Mar 2, 2022

Anesthesia, Regional Trial in Toronto (Femoral Articular Branch Block, Placebo Block)

Recruiting
  • Anesthesia, Regional
  • Femoral Articular Branch Block
  • Placebo Block
  • Toronto, Ontario, Canada
    Women's College Hospital
Oct 18, 2021

Pancreatic Cancer Trial run by the (ipilimumab)

Completed
Has Results
  • Pancreatic Cancer
  • ipilimumab
  • Bethesda, Maryland
  • +1 more
Sep 24, 2021

Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis Trial in Iowa City, Philadelphia, Ghent (QR-110)

Active, not recruiting
  • Leber Congenital Amaurosis 10
  • +9 more
  • Iowa City, Iowa
  • +2 more
Feb 8, 2022

Stroke, Acute Trial in Worcester (MR-010)

Recruiting
  • Stroke, Acute
  • MR-010
  • Worcester, Massachusetts
    UMass Chan Medical School
Feb 8, 2022

Thalassemia Trial in Canada, United Kingdom, United States (AG-348)

Active, not recruiting
Has Results
  • Thalassemia
  • Oakland, California
  • +3 more
Jan 26, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +5 more
  • (no location specified)
Jul 21, 2023

Prostatic Tumors Trial in Worldwide (Pembrolizumab, Olaparib, Abiraterone acetate)

Active, not recruiting
  • Prostatic Neoplasms
  • Pembrolizumab
  • +4 more
  • Fullerton, California
  • +192 more
Oct 17, 2022

First-line Treatment, Advanced Gastric Carcinoma Trial in Tianjin (Lenvatinib)

Recruiting
  • First-line Treatment
  • Advanced Gastric Carcinoma
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jan 23, 2022

Koebner in Patients With Psoriasis and Psoriatic Arthritis

Not yet recruiting
  • Psoriasis
  • +2 more
    • (no location specified)
    Oct 18, 2022

    Hematologic Malignancy Trial in Duarte (B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010))

    Recruiting
    • Hematologic Malignancy
    • B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010)
    • Duarte, California
      City of Hope
    Oct 20, 2023

    Melanoma Trial in Nedlands, Haifa, Jerusalem (Pembrolizumab/Vibostolimab, Pembrolizumab)

    Recruiting
    • Melanoma
    • Pembrolizumab/Vibostolimab
    • Pembrolizumab
    • Nedlands, Western Australia, Australia
    • +2 more
    Jan 31, 2023

    Dyskinesias Trial in Worldwide (JM-010 group A, JM-010 group B, Placebos)

    Recruiting
    • Dyskinesias
    • JM-010 group A
    • +2 more
    • Toulouse, France
    • +3 more
    Nov 9, 2021

    COVID-19 Trial in Taiyuan, Chengdu (Candidate Vaccine, SCB-2019, Placebo)

    Active, not recruiting
    • COVID-19
    • Candidate Vaccine, SCB-2019
    • Placebo
    • Taiyuan, Shanxi, China
    • +1 more
    Feb 22, 2022

    Advanced Solid Tumors Trial in Beijing (GLS-010)

    Active, not recruiting
    • Advanced Solid Tumors
    • Beijing, Beijing, China
      Peking University Cancer Hospital & Institute
    Dec 1, 2021

    Respiratory Syncytial Virus Infections Trial (RSVPreF3 vaccine, Control)

    Not yet recruiting
    • Respiratory Syncytial Virus Infections
    • RSVPreF3 vaccine
    • Control
    • (no location specified)
    Jan 20, 2023

    Knowledge, Attitudes, Practices Trial in Cape Coast, Accra (WHO QualityRights e-training, WHO COVID-19 online training)

    Active, not recruiting
    • Knowledge
    • +2 more
    • WHO QualityRights e-training
    • WHO COVID-19 online training
    • Cape Coast, Central, Ghana
    • +2 more
    Jun 13, 2022

    Solid Tumor, Cutaneous Squamous Cell Carcinoma, Endometrial Cancer Trial (favezelimab/pembrolizumab, pembrolizumab, lenvatinib)

    Not yet recruiting
    • Solid Tumor
    • +2 more
    • favezelimab/pembrolizumab
    • +2 more
    • (no location specified)
    Sep 7, 2023

    Atopic Dermatitis Trial (BMX-010, Placebo)

    Not yet recruiting
    • Atopic Dermatitis
    • (no location specified)
    Aug 4, 2022

    Psoriasis, Atopic Dermatitis Trial in United States (BMX-010, Placebo)

    Completed
    • Psoriasis
    • Atopic Dermatitis
    • Encino, California
    • +9 more
    Oct 4, 2021

    Diabetic Autonomic Neuropathy Trial in Norfolk (Cycloset, Placebo)

    Completed
    Has Results
    • Diabetic Autonomic Neuropathy
    • Norfolk, Virginia
      Eastern Virgnia Medical School, Strelitz Diabetes Center
    Nov 12, 2021

    Relapsed/Refractory DLBCL (DLBCL) Trial in China (ATG-010 60 mg, orally, twice weekly, each 4 week (28-day) a cycle)

    Recruiting
    • Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
    • ATG-010 60 mg, orally, twice weekly, each 4 week (28-day) a cycle
    • Beijing, Beijing, China
    • +14 more
    Jul 19, 2021